Structure Empowered IMPACT Platform in the Discovery & Development of Immunoglobulin Sculpting (IgSc) Enzyme & Dual-Cell Bidirectional (DcB) Antibody Drugs for Immunological Diseases
Time: 1:45 pm
day: Day 2
Details:
- Understanding the structural biology function and IMPACT platform
- Exploring how structure-based rational design and machine learning design fueled drug discovery and development of IgSc enzyme
- DcB antibody-antigen structures supporting the development of biologic drugs
